Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.
3.
4.

Molecular modelling study of the binding of inhibitors of aromatase to the cytochrome P-450 heme.

Ahmed S, Davis PJ, Owen CP.

Drug Des Discov. 1996 Oct;14(2):91-102.

PMID:
9010616
5.

Imidazole derivatives of pyrrolidonic and piperidonic as potential inhibitors of human placental aromatase in vitro.

Baroudi M, Robert J, Luu-Duc C.

J Steroid Biochem Mol Biol. 1996 Jan;57(1-2):73-7.

PMID:
8645619
6.

Synthesis and aromatase inhibition of 3-cycloalkyl-substituted 3-(4-aminophenyl)piperidine-2,6-diones.

Hartmann RW, Batzl C, Pongratz TM, Mannschreck A.

J Med Chem. 1992 Jun 12;35(12):2210-4.

PMID:
1613747
7.

Aromatase inhibitors: synthesis, biological activity, and binding mode of azole-type compounds.

Furet P, Batzl C, Bhatnagar A, Francotte E, Rihs G, Lang M.

J Med Chem. 1993 May 14;36(10):1393-400.

PMID:
8496907
9.
10.

1-[(Benzofuran-2-yl)phenylmethyl]-triazoles and -tetrazoles - potent competitive inhibitors of aromatase.

Vinh TK, Ahmadi M, Delgado PO, Perez SF, Walters HM, Smith HJ, Nicholls PJ, Simons C.

Bioorg Med Chem Lett. 1999 Jul 19;9(14):2105-8.

PMID:
10450990
12.

Aromatase inhibition by an 11,13-dihydroderivative of a sesquiterpene lactone.

Blanco JG, Gil RR, Bocco JL, Meragelman TL, Genti-Raimondi S, Flury A.

J Pharmacol Exp Ther. 2001 Jun;297(3):1099-105.

13.

Synthesis and evaluation of benzimidazole and imidazole compounds as potential aromatase inhibitors.

Hida F, Robert J, Luu-Duc C.

Farmaco. 1994 Jul-Aug;49(7-8):489-92.

PMID:
7945714
14.

An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors.

Neves MA, Dinis TC, Colombo G, Sá e Melo ML.

Eur J Med Chem. 2009 Oct;44(10):4121-7. doi: 10.1016/j.ejmech.2009.05.003. Epub 2009 May 19.

PMID:
19500885
15.

3-(1H-pyrrol-2-yl)-2-oxazolidinones as novel monoamine oxidase type A inhibitors.

Mai A, Artico M, Valente S, Sbardella G, Turini P, Befani O, Vedova LD, Agostinelli E.

Med Chem. 2005 Mar;1(2):117-24.

PMID:
16787307
16.

Structure-activity relationships of new A,D-ring modified steroids as aromatase inhibitors: design, synthesis, and biological activity evaluation.

Cepa MM, Tavares da Silva EJ, Correia-da-Silva G, Roleira FM, Teixeira NA.

J Med Chem. 2005 Oct 6;48(20):6379-85.

PMID:
16190763
17.

Synthesis of conformationally constrained analogues of linezolid: structure-activity relationship (SAR) studies on selected novel tricyclic oxazolidinones.

Selvakumar N, Srinivas D, Khera MK, Kumar MS, Mamidi RN, Sarnaik H, Charavaryamath C, Rao BS, Raheem MA, Das J, Iqbal J, Rajagopalan R.

J Med Chem. 2002 Aug 29;45(18):3953-62.

PMID:
12190317
18.

Computational approach to drug design for oxazolidinones as antibacterial agents.

Li Y, Wei DQ, Gao WN, Gao H, Liu BN, Huang CJ, Xu WR, Liu DK, Chen HF, Chou KC.

Med Chem. 2007 Nov;3(6):576-82.

PMID:
18045208
19.

Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity.

Jackson T, Woo LW, Trusselle MN, Chander SK, Purohit A, Reed MJ, Potter BV.

Org Biomol Chem. 2007 Sep 21;5(18):2940-52. Epub 2007 Aug 7. Erratum in: Org Biomol Chem. 2007 Oct 21;5(20):3368. Corrected and republished in: Org Biomol Chem. 2007 Oct 21;5(20):2940-52.

PMID:
17728860
20.

2- and 3-[(aryl)(azolyl)methyl]indoles as potential non-steroidal aromatase inhibitors.

Lézé MP, Le Borgne M, Marchand P, Loquet D, Kogler M, Le Baut G, Palusczak A, Hartmann RW.

J Enzyme Inhib Med Chem. 2004 Dec;19(6):549-57.

PMID:
15662958

Supplemental Content

Support Center